HEALTHCARE GLOB. ENT. LTD (HCG) financials

HEALTHCARE GLOB. ENT. LTD (HCG) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

Market Cap: ₹8,782Cr.
Current Price: ₹588
Stock P/E: 130
ROE: 4.71%
ROCE: 6.13%
Book Value: ₹107
Dividend Yield: 0.00%
52W High / Low: ₹800/513

In Jun 2026, HEALTHCARE GLOB. ENT. LTD (HCG) reported sales ₹376.66 Cr and net profit ₹5.58 Cr.

Annual TTM: sales ₹1,415 Cr, net profit ₹17 Cr.

Shareholding: Promoters 64.21% (Sep 2026), FIIs 2.70% (Sep 2026), DIIs 20.78% (Sep 2026), Public 12.32% (Sep 2026), No. of Shareholders 44,774% (Sep 2026).

HCG quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	329.25	312.51	324.38	327.09	345.84	342.16	350.21	376.66
Expenses	267.67	270.19	265.49	277.24	283.54	287.86	275.07	317.44
Operating Profit	61.58	42.32	58.89	49.85	62.30	54.30	75.14	59.22
OPM %	18.70%	13.54%	18.15%	15.24%	18.01%	15.87%	21.46%	15.72%
Other Income	9.79	-29.53	9.46	7.94	3.82	-4.87	-32.60	9.56
Interest	20.58	21.27	22.50	24.30	21.36	20.61	20.19	21.73
Depreciation	27.88	27.90	29.05	28.25	30.16	30.09	31.30	39.57
Profit before tax	22.91	-36.38	16.80	5.24	14.60	-1.27	-8.95	7.48
Tax %	21.65%	2.61%	39.58%	34.16%	26.16%	-7.09%	-117.09%	25.40%
Net Profit	17.95	-37.33	10.15	3.45	10.78	-1.18	1.53	5.58
EPS in Rs	1.22	-2.53	0.69	0.23	0.72	-0.08	0.10	0.37
Raw PDF	—	—	—	—	—	—	—	—

HCG profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	688	609	850	1,006	1,171	1,277	1,359	1,415
Expenses	573	535	703	824	970	1,065	1,124	1,164
Operating Profit	116	74	147	181	201	211	236	251
OPM %	17%	12%	17%	18%	17%	17%	17%	18%
Other Income	-19	-129	65	7	0	4	-20	-24
Interest	83	63	43	41	50	84	86	84
Depreciation	79	87	88	89	97	111	120	131
Profit before tax	-65	-205	81	58	54	20	10	12
Tax %	-19%	-7%	53%	30%	39%	82%	-52%	—
Net Profit	-53	-192	38	40	33	4	15	17
EPS in Rs	-5.68	-14.43	2.60	2.73	2.22	0.24	0.98	1.11
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

HCG balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	88	89	125	139	139	139	139	149
Reserves	557	526	798	959	1,006	1,042	1,052	1,455
Borrowings	422	827	481	349	347	758	1,118	1,022
Other Liabilities	337	328	169	197	237	299	295	291
Total Liabilities	1,404	1,769	1,575	1,644	1,730	2,239	2,604	2,917
Fixed Assets	547	914	745	774	788	974	1,038	1,122
CWIP	104	44	28	5	9	36	23	14
Investments	299	316	366	439	475	506	696	704
Other Assets	454	495	436	426	458	722	847	1,078
Total Assets	1,404	1,769	1,575	1,644	1,730	2,239	2,604	2,917

HCG cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	87	86	71	124	130	209	146	160
Cash from Investing Activity	-208	-116	-246	49	-138	-254	-347	-76
Cash from Financing Activity	66	-3	236	-41	-42	96	-42	336
Net Cash Flow	-55	-32	61	132	-49	51	-243	421
Free Cash Flow	-36	6	48	82	36	80	13	8
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	120%	92%	41%	95%	81%	121%	78%	72%

HCG shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	71.22%	71.22%	62.46%	63.78%	63.77%	64.21%	64.21%	64.21%
FIIs	2.77%	2.44%	2.16%	3.59%	3.22%	2.76%	2.73%	2.70%
DIIs	12.94%	12.48%	13.22%	18.36%	18.30%	18.91%	19.20%	20.78%
Public	13.07%	13.86%	22.17%	14.28%	14.71%	14.15%	13.86%	12.32%
No. of Shareholders	32,820	45,394	47,028	46,970	45,366	47,649	48,905	44,774

HCG key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	83	81	88	69	77	69	75	70
Inventory Days	39	31	32	30	33	30	23	26
Days Payable	253	247	214	167	168	192	175	168
Cash Conversion Cycle	-131	-135	-94	-68	-59	-93	-77	-71
Working Capital Days	-82	-133	38	9	26	-37	-70	-33
ROCE %	6%	4%	1%	5%	7%	7%	7%	6%

HCGUpdated 18 Oct 2026, 2:23

Healthcare Glob. Ent. Ltd

HCGUpdated 18 Oct 2026, 2:23

Market Cap

₹8,782Cr.

Current Price

₹588

High / Low

₹800/513

Stock P/E

130

ROE4.71%

ROCE6.13%

Book Value₹107

Face Value₹10.0

Dividend Yield0.00%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	272.23	9.69	224.69	1.83	21.64	18.04	24.11	13.69	0.93
Sep 2023	282.75	10.98	232.34	2.13	23.28	18.28	25.05	13.7	0.93
Dec 2023	285.81	13.7	237.06	5.04	24.8	15.29	43.3	8.67	0.59
Mar 2024	299.93	14.61	243.32	-12.43	25.9	3.67	145.78	-1.68	-0.11
Jun 2024	293.61	19.34	243.72	10.5	25.84	15.21	22.95	11.72	0.79
Sep 2024	329.25	20.58	267.67	9.79	27.88	22.91	21.65	17.95	1.22
Dec 2024	312.51	21.27	270.19	-29.53	27.9	-36.38	2.61	-37.33	-2.53
Mar 2025	324.38	22.5	265.49	9.46	29.05	16.8	39.58	10.15	0.69
Jun 2025	327.09	24.3	277.24	7.94	28.25	5.24	34.16	3.45	0.23
Sep 2025	345.84	21.36	283.54	3.82	30.16	14.6	26.16	10.78	0.72
Dec 2025	342.16	20.61	287.86	-4.87	30.09	-1.27	-7.09	-1.18	-0.08
Mar 2026	350.21	20.19	275.07	-32.6	31.3	-8.95	-117.09	1.53	0.1
Jun 2026	376.66	21.73	317.44	9.56	39.57	7.48	25.4	5.58	0.37

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	420	32	364	0	33	-8	-69	-2	-0.32
Mar 2016	471	34	407	-1	37	-9	-45	-5	-0.52
Mar 2017	545	16	462	7	44	29	34	19	2.15
Mar 2018	586	27	498	19	44	37	32	25	2.71
Mar 2019	640	48	546	13	47	13	42	7	0.78
Mar 2020	688	83	573	-19	79	-65	-19	-53	-5.68
Mar 2021	609	63	535	-129	87	-205	-7	-192	-14.43
Mar 2022	850	43	703	65	88	81	53	38	2.6
Mar 2023	1006	41	824	7	89	58	30	40	2.73
Mar 2024	1171	50	970	0	97	54	39	33	2.22
Mar 2025	1277	84	1065	4	111	20	82	4	0.24
Mar 2026	1359	86	1124	-20	120	10	-52	15	0.98
TTM	1415	84	1164	-24	131	12	—	17	1.11

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	64.21%
FIIs	2.7%
DIIs	20.78%
Public	12.32%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	71.29%	6.37%	8.46%	13.89%
Mar 2024	71.28%	6.74%	8.52%	13.45%
Jun 2024	71.26%	3.95%	10.89%	13.9%
Sep 2024	71.23%	4.3%	11.64%	12.84%
Dec 2024	71.22%	2.77%	12.94%	13.07%
Mar 2025	71.22%	2.44%	12.48%	13.86%
Jun 2025	62.46%	2.16%	13.22%	22.17%
Sep 2025	63.78%	3.59%	18.36%	14.28%
Dec 2025	63.77%	3.22%	18.3%	14.71%
Mar 2026	64.21%	2.76%	18.91%	14.15%
Jun 2026	64.21%	2.73%	19.2%	13.86%
Sep 2026	64.21%	2.7%	20.78%	12.32%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	70	202	311	107	690	405	28	84	173	690
Mar 2016	85	435	194	136	850	431	29	155	235	850
Mar 2017	86	459	218	159	923	442	33	141	306	923
Mar 2018	87	552	264	210	1112	492	79	219	322	1112
Mar 2019	88	557	422	337	1404	547	104	299	454	1404
Mar 2020	89	526	827	328	1769	914	44	316	495	1769
Mar 2021	125	798	481	169	1575	745	28	366	436	1575
Mar 2022	139	959	349	197	1644	774	5	439	426	1644
Mar 2023	139	1006	347	237	1730	788	9	475	458	1730
Mar 2024	139	1042	758	299	2239	974	36	506	722	2239
Mar 2025	139	1052	1118	295	2604	1038	23	696	847	2604
Mar 2026	149	1455	1022	291	2917	1122	14	704	1078	2917

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	51	-74	22	-1
Mar 2016	58	-86	120	92
Mar 2017	54	-73	-14	-33
Mar 2018	66	-185	91	-27
Mar 2019	87	-208	66	-55
Mar 2020	86	-116	-3	-32
Mar 2021	71	-246	236	61
Mar 2022	124	49	-41	132
Mar 2023	130	-138	-42	-49
Mar 2024	209	-254	96	51
Mar 2025	146	-347	-42	-243
Mar 2026	160	-76	336	421

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	56	54	67	79	83	81	88	69	77	69	75	70
Inventory Days	36	30	36	40	39	31	32	30	33	30	23	26
Days Payable	208	266	257	269	253	247	214	167	168	192	175	168
Cash Conversion Cycle	-116	-182	-154	-150	-131	-135	-94	-68	-59	-93	-77	-71
Working Capital Days	-64	-74	-69	-24	-82	-133	38	9	26	-37	-70	-33
ROCE %	5%	5%	6%	7%	6%	4%	1%	5%	7%	7%	7%	6%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of HEALTHCARE GLOB. ENT. LTD (HCG)?

The reported market capitalisation for HEALTHCARE GLOB. ENT. LTD (HCG) is ₹8,782Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of HCG?

The current price shown for HEALTHCARE GLOB. ENT. LTD (HCG) on Fincrux is ₹588 with a 52-week high/low of ₹800/513.

What is the P/E ratio of HEALTHCARE GLOB. ENT. LTD (HCG)?

The stock P/E for HEALTHCARE GLOB. ENT. LTD (HCG) is 130 on Fincrux, with ROE at 4.71% and ROCE at 6.13%.

What were HCG latest quarterly results?

For Jun 2026, HEALTHCARE GLOB. ENT. LTD (HCG) reported sales ₹376.66 Cr and net profit ₹5.58 Cr (figures in ₹ crore unless noted).

What are HCG annual sales and net profit?

For TTM, HEALTHCARE GLOB. ENT. LTD (HCG) shows sales of ₹1,415 Cr and net profit of ₹17 Cr on the Fincrux profit & loss statement.

Who owns HEALTHCARE GLOB. ENT. LTD (HCG)?

Latest shareholding for HEALTHCARE GLOB. ENT. LTD (HCG) on Fincrux: Promoters 64.21% (Sep 2026), FIIs 2.70% (Sep 2026), DIIs 20.78% (Sep 2026), Public 12.32% (Sep 2026), No. of Shareholders 44,774% (Sep 2026).

Where can I find HEALTHCARE GLOB. ENT. LTD (HCG) financials?

HEALTHCARE GLOB. ENT. LTD (HCG) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show HCG balance sheet and cash flow?

Yes. The HEALTHCARE GLOB. ENT. LTD (HCG) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 2:23